Provided by Tiger Fintech (Singapore) Pte. Ltd.

Elicio Therapeutics

5.07
-0.1500-2.87%
Volume:116.46K
Turnover:616.89K
Market Cap:80.81M
PE:-1.19
High:5.60
Open:5.25
Low:5.00
Close:5.22
Loading ...
Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 12, 2024

Major Issues Report

Form 8-K - Current report
Jul 02, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Jun 29, 2024

Major Issues Report

Form 8-K - Current report
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Correspondence

Form CORRESP - Correspondence
Jun 08, 2024

Correspondence

Form CORRESP - Correspondence
Jun 04, 2024

Correspondence

Form CORRESP - Correspondence
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2024

Major Issues Report

Form 8-K - Current report
Apr 29, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 10, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 05, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2024

Major Issues Report

Form 8-K - Current report
Mar 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 18, 2024

Major Issues Report

Form 8-K - Current report